Major Rating Factors:
Poor long-term capitalization index (0.0 on a scale of 0 to 10) based on weak current risk adjusted capital (severe and moderate loss scenarios). A history of deficient reserves (0.2) that places pressure on both capital and profits. In four of the last five years reserves (two year development) were between 37.5% and 108.8% deficient. Weak profitability index (0.8) with operating losses during 2022, 2023, 2024 and 2025.
Other Rating Factors:
Vulnerable liquidity (0.0) as a spike in claims may stretch capacity. Weak overall results on stability tests (0.9) including weak results on operational trends, weak risk diversification and negative cash flow from operations for 2025. The largest net exposure for one risk is excessive at 11.2% of capital.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
L - Past results on our liquidity tests.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
NV
Principal Investments:
Investment grade bonds (74.9%), cash (24.1%), common stock (0.3%), other (0.6%)
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
200 East Robinson Street
Orlando, FL 32801
Orlando, FL 32801
Phone Number
(407) 898-9560
NAIC Number
12003
Website
Largest Affiliates
There are no affiliate to display.